Insights

Our Progress

Event Recap: Biomeme 10 Years Celebration

As August comes to a close, we complete our reflective journey through the last 10 years of Biomeme history and the obstacles, achievements, late nights, connections, partnerships, pots of coffee...

Read More

Search By Topic

Get the latest tips from Biomeme shipped right to your inbox

Our People

Note from Our CEO: Biomeme 10 Years in the Making

As CEO, I am extremely proud to be marking Biomeme’s 10th anniversary as a company — a significant milestone. In 2012, Marc DeJohn, Jesse vanWestrienen and I started Biomeme. In a decade, we went...

Read More
Our Progress

Celebrating a Decade at the Forefront of Molecular Detection: Biomeme’s 10th Anniversary

Step Back into 2012: The space shuttle had its final flight (Endeavor) and the Curiosity rover landed on Mars. Apple introduced the iPhone 5. The Mesoamerican Long Count calendar reached the date...

Read More
Our Progress

A Message from Biomeme on World Health Day

Every year the World Health Organization (WHO) celebrates World Health Day on April 7th and takes the opportunity to draw attention to a specific health topic of concern to people all over the world....

Read More
Our People

Biomeme Spotlight: A Chat with Women in Our Workplace

We’ve talked a lot about the immense growth has seen in recent years. Throughout our growth we’ve had people from all walks of life, all over the world, and of all kinds of perspectives work...

Read More
Product Updates

Frequently Asked Questions: Biomeme and Predigen Merger

Biomeme recently announced the completed acquisition of Predigen. The announcement brings together Predigen's combined decades of host response research with Biomeme's portable PCR test solutions to...

Read More
Our Progress

Welcome to the New Biomeme HQ

New Year, New Biomeme Headquarters We are settled in and so glad to finally welcome our employees, customers, and everyone involved with Biomeme's success to our new headquarters space. To recap, we...

Read More
Our Progress

Biomeme to Receive Portion of $21 Million Investment for Molecular Diagnostic Testing in LMICs

FIND, the global alliance for diagnostics, announced on December 20, 2021 a US$21 million investment to accelerate the development, manufacturing, and launch of affordable, multi-pathogen, molecular...

Read More
Product Updates

What We Know About Omicron Variant

Through in silico analysis, we’ve confirmed Biomeme’s SARS-Cov-2 assay detects all current variants of concern and variants of interest including delta and omicron. Omicron was first identified in...

Read More
Our Progress

Event Recap: 2021 Nucleus Awards Presented by the University City Science Center

Each year, the University City Science Center’s Nucleus Awards bring together the region’s leaders and groundbreakers in innovation, all while supporting Philadelphia’s future as a hub of innovation...

Read More
Prev 1 2 3 4 5 Next